My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hercules Capital, Inc. Common Stock (NY:HTGC)

19.11 +0.01 (+0.05%)
Official Closing Price Updated: 7:00 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 million financing for launch readiness. 
Via Benzinga
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
From uniQure Inc.
Via GlobeNewswire
Hercules Capital Receives Investment Grade Rating Upgrade to Baa2 With Revised Outlook to Stable From Moody’s Investors Service
From Hercules Capital, Inc.
Via Business Wire
Earnings Scheduled For July 31, 2025
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
2 Safe-and-Steady Stocks to Target This Week and 1 We Brush Off
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
3 Small-Cap Stocks We Steer Clear Of
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
1 Financials Stock with Promising Prospects and 2 We Ignore
Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. But uncertainty about fiscal and... 
Via StockStory
Topics Credit Cards Economy Stocks
Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing
From Snappt
Via Business Wire
Hercules Capital Reports Second Quarter 2025 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2025
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital’s Wholly-Owned Investment Adviser Launches Fourth Institutional Private Credit Fund
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Recent Report Shows That Rep. Virginia Foxx Sold Up to $65K Worth of Energy Transfer Stock
 
Via Benzinga
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
From Hercules Capital, Inc.
Via Business Wire
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
From Dyne Therapeutics, Inc.
Via GlobeNewswire
Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030
From Hercules Capital, Inc.
Via Business Wire
Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report
Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff. 
Via Benzinga
Topics Intellectual Property
Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports First Quarter 2025 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.47 Per Share for the First Quarter 2025
From Hercules Capital, Inc.
Via Business Wire
50-Year-Old Investor Craves 8%+ Yield, Snubs Ford, Chases Durable Dividends – 'I Am Willing To Consider Anything' For Monthly Income
In today's unpredictable market, investors seeking high yields need to balance risk and reward carefully. With rising volatility, inflation concerns, and fluctuating interest rates, a well-diversified... 
Via Benzinga
Topics Economy
Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc.
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc.
From Hercules Capital, Inc.
Via Business Wire
What Analysts Are Saying About Hercules Capital Stock
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.